Clinical Trials

Toll-Free: 866.320.4573

Call Us Toll Free:

866.223.2273 x1234

Capsule Endoscopy for Post-Ablation Esophageal Lesion Assessment

Study:

CEPELA I Trial: Capsule Endoscopy for Post-Ablation Esophageal Lesion Assessment

Rationale:

n/a

Purpose:

Patients undergoing radiofrequency ablation (RFA) therapy for atrial fibrillation, can sometimes experience insult or injury to the esophagus, due to the proximity of the esophagus to the RFA treatment area. This study utilizes a disposable capsule endoscope (Pillcam ESO) to assess the condition of a patient`s esophagus before and after the RFA procedure, as the injury rate to the esophagus has not been established.

Study Status: Completed

Recruiting:
n/a

Condition Intervention Phase
Esophageal Lesion Device: PillCam ESO Capsule Endoscope N/A

Verified by The Cleveland Clinic March, 2012

Sponsored by: The Cleveland Clinic
Information provided by: The Cleveland Clinic
ClinicalTrials.gov identifier: NCT00990782

Study Type: Interventional

Study Design: Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Diagnostic

Cleveland Clinic
Cleveland, Ohio 44195
United States

Milan Dodig, MD., Principal Investigator

This information is abridged to display results relevant only to Cleveland Clinic. To see complete record visit ClinicalTrials.gov
  Information obtained from ClinicalTrials.gov on
Link to the current ClinicalTrials.gov record.

Cleveland Clinic Mobile Site